Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Despite the website advertising 48-hour delivery, mine arrived overnight
Lilly will present more data from its diabetes and obesity pipeline tomorrow at ADA, including more for Foundayo in diabetes and longer-term data for Mounjaro
There is no formal contraindication to using tirzepatide and testosterone together, as they work through different mechanisms and metabolic pathways
A 6% dropout rate for a treatment producing 22.7% weight loss is remarkably low
Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus
